You are here

Merck

ESMO 2022 – Keytruda secures a renal cancer monopoly

EP Vantage

Thu, 09/8/22 - 12:03 am

Bristol Myers Squibb

Merck's Deal With Seagen May Have Fallen Through. Now What?

Motley Fool

Wed, 09/7/22 - 10:16 am

Merck and Seagen can't agree on a price for their rumored merger

Fierce Pharma

Fri, 08/26/22 - 10:43 am

Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers

BioPharma Dive

Thu, 08/25/22 - 10:55 am

radiopharmaceuticals

Bristol Myers Squibb

Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant

Fierce Biotech

Tue, 08/23/22 - 10:32 am

end-stage renal disease

Merck Makes Another Big R&D Investment with $3.5B Orna Deal

BioSpace

Tue, 08/16/22 - 12:10 pm

Orna Therapeutics

infectious disease

With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2

Fierce Pharma

Mon, 08/15/22 - 10:35 am

Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe

Yahoo/Zacks.com

Fri, 08/12/22 - 10:12 am

FDA says found possible carcinogen in certain samples of Merck's Januvia

Yahoo/Reuters

Tue, 08/9/22 - 11:51 pm

Merck is back in Alzheimer's saddle with $1B+ Cerevance pact, years after dropping the BACE

Fierce Biotech

Tue, 08/9/22 - 10:42 am

Alzheimer's disease

Merck plans to count coughs and months until gefapixant is back in FDA hands

Fierce Biotech

Fri, 08/5/22 - 10:54 am

Merck's Keytruda, on a losing streak, fails in once FDA-rejected liver cancer use and prostate cancer—again

Fierce Pharma

Wed, 08/3/22 - 09:15 pm

Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data

Fierce Pharma

Tue, 08/2/22 - 10:54 am

clinical trials

checkpoint inhibitors

Merck picks up another ADC agreement

Biopharma Reporter

Tue, 08/2/22 - 10:50 am

antibody-drug conjugate

Sichuan Kelun Pharmaceutical

Drugmakers leap back into fading heart drug market

Beckers Hospital Review

Thu, 07/28/22 - 06:40 pm

Bristol Myers Squibb

Alnylam Pharmaceuticals

Merck Dives As Drug-Pricing Bills Undercut Second-Quarter Profit

Investors Business Daily

Thu, 07/28/22 - 06:37 pm

Merck dodged billions in US taxes in offshoring Keytruda profits, Senate Democrats contend

Fierce Pharma

Thu, 07/28/22 - 11:06 am

Senate Finance chair calls on Merck and Abbott to comply with his investigation into their offshore tax schemes

Endpoints

Wed, 07/27/22 - 06:48 pm

Merck's ADC hunt continues with second deal for China biotech Kelun

Endpoints

Tue, 07/26/22 - 05:24 pm

antibody-drug conjugate

Seagen, Astellas claim positive results in study key to cancer drug's success

BioPharma Dive

Tue, 07/26/22 - 11:26 am

clinical trials

Pages